Stock listing
Corestemchemon Inc.
Selected listing: 166480 · KRX · KRW · KR
Corestemchemon Inc. (KRX:166480), Health Technology. Latest release Sep 17, 2025: Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025…
- Ticker
- KRX:166480
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Corestemchemon Inc.
Corestemchemon Inc. is a public company based in Korea, trading under the ticker 166480. Corestemchemon Inc. focuses on its operations within the chemical sector, contributing to various industrial applications.
Latest news from Corestemchemon Inc.
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway
September 16, 2025
CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services
July 19, 2025
Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
May 29, 2025